NR1H4 and metabolic dysfunction-associated steatotic liver disease: In contrast to the activation of hepatic FXR, the activation of intestinal FXR in NAFLD mice has been associated with the promotion of NAFLD through the FXR-FGF15 signaling pathway [17,18,19].